Mymom,
I'll send you the extracts of the Lodge report issued in Nov 2006. It clearly shows that the reponse was very limited to the Cvac trial. Talks of PhIII taking another three years.
Where to you think PRR is going to get the funds to stay alive? No corporate players are interested and I have spoken to many including the CEO's of other listed biotechs.
They are very critical of PRR and Eugene and are not beating down the door to get hold of PRR's protfolio.
a morning joke sth cross equity report, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.005(1.82%) |
Mkt cap ! $407.2M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.5¢ | 27.0¢ | $352.6K | 1.266M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 156231 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 2491 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |